Kestra Medical Technologies, Ltd. (KMTS) scores 51 out of 100 on boothcheck's 11-model valuation framework. Verdict: Poor The estimated fair value is 2.71, representing a 86% premium to fair value. Quantitative score: 51/100. Qualitative score: 70/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.